Current development of cabazitaxel drug delivery systems

B Sun, JF Lovell, Y Zhang - Wiley Interdisciplinary Reviews …, 2023 - Wiley Online Library
The second‐generation taxane cabazitaxel has been clinically approved for the treatment of
metastatic castration‐resistant prostate cancer after docetaxel failure. Compared with the …
被引用次数：24 相关文章
[PDF] researchgate.net

[PDF][PDF] Current development of cabazitaxel drug delivery systems

B Sun, JF Lovell, Y Zhang - researchgate.net
The second-generation taxane cabazitaxel has been clinically approved for the treatment of
metastatic castration-resistant prostate cancer after docetaxel failure. Compared with the first …

Current development of cabazitaxel drug delivery systems.

B Sun, JF Lovell, Y Zhang - Wiley Interdisciplinary reviews …, 2022 - europepmc.org
The second-generation taxane cabazitaxel has been clinically approved for the treatment of
metastatic castration-resistant prostate cancer after docetaxel failure. Compared with the first …

Current development of cabazitaxel drug delivery systems

B Sun, JF Lovell, Y Zhang - Wiley interdisciplinary reviews …, 2023 - pubmed.ncbi.nlm.nih.gov
The second-generation taxane cabazitaxel has been clinically approved for the treatment of
metastatic castration-resistant prostate cancer after docetaxel failure. Compared with the first …